hcp home
product info
safety
prescribing information
elan pain information center
prialt.com
Search
Go
Advanced
About PRIALT
History of Discovery
How PRIALT Works
Efficacy Information
Safety Information
Case Studies
Dosing
Administration
How to Order
Reimbursement Information
Overview
Claims Tracking
Payer Coverage
Billing and Coding
Forms and Documents
+
Medical Necessity
+
Denied Claims
Medical Assistance Programs
Patient Education Materials
Available Materials
Related Links and Resources
Related Resources
American Pain Foundation
National Pain Foundation
National Organization for Rare Disorders
Effective Neuropathic Pain Management
Important Safety Considerations
Warning: Severe psychiatric symptoms and neurological impairment may occur during treatment with PRIALT. Patients with a pre-existing history of psychosis should not be treated with PRIALT. All patients should be monitored frequently for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness. PRIALT therapy can be interrupted or discontinued abruptly without evidence of withdrawal effects in the event of serious neurological or psychiatric signs or symptoms.
PRIALT is for use only in the Medtronic SynchroMed
®
EL,
SynchroMed
®
II Infusion System and the CADD-Micro ambulatory infusion pump.
This website is intended for residents of the United States, Puerto Rico, and US Territories.
PRIALT
®
is a registered trademark and
is a trademark of Elan Pharmaceuticals, Inc.
SynchroMed
®
is a registered trademark of Medtronic, Inc.
is a trademark of Elan Pharmaceuticals, Inc.